MKR Clinical Research Consultants

Executive Summary

MKR Clinical Research Consultants, founded in 1995 and headquartered in San Diego, is a private clinical research organization (CRO) offering comprehensive trial management services. The company specializes in project management, regulatory affairs, biostatistics, site selection, feasibility, and eCRF design, as well as medical monitoring with a global team of CRAs and lead CRAs. With over 25 years of experience, MKR positions itself as a one-stop solution for sponsors seeking efficient and reliable clinical study execution. Its focus on quality control visits and co-monitoring services differentiates it in a competitive CRO landscape, though the company remains relatively small and private, with limited public visibility. The CRO industry is experiencing steady growth driven by increasing R&D outsourcing by pharmaceutical and biotech firms. MKR could benefit from this trend, but lacks major recent news or funding rounds to suggest near-term inflection points. The company’s long track record and specialized medical monitoring services provide a stable foundation, but without clear expansion plans or disclosed financials, its growth trajectory is uncertain. Given the private nature and absence of publicly disclosed catalysts, the conviction is modest. The main opportunities lie in potential new contract wins or partnerships, though these are speculative.

Upcoming Catalysts (preview)

• TBDMajor Contract Win with Large Pharma30% success
• Q3 2026Expansion into Decentralized Clinical Trials Services40% success
• TBDRegulatory Changes Favorable to Smaller CROs50% success